个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

【已隐藏】Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)

| 认领 | 导出 |

本文已应作者要求隐藏

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
J. Yu[1] ; L. Xing[1] ; G. Cheng[2] ; L. Chen[3] ; L. Dong[4] ; X. Fu[5] ; Y. Guo[6] ; Z. Han[7] ; D. Jiang[8] ; J. Li[9] ; Y. Lin[10] ; A. Liu[11] ; J. Liu[12] ; J. Liu[8] ; Y. Liu[13] ; D. Lv[14] ; C. Ma[15] ; Y. Ren[16] ; S. Wang[17] ; Y. Wang[18] ; C. Xiao[19] ; S. Yan[20] ; F. Yang[21] ; W. Yang[22] ; A. Zang[23] ; X. Zhang[24] ; Y. Zhang[25] ; R. Zhao[26] ; J. Zhou[27] ;
机构： [1]Shandong Cancer Hospital, Jinan/CN [2]Humanity & Health Research Center, Hong Kong/CN [3]Cancer Hospital of Guangxi Medical University, Nanning/CN [4]The First Hospital of Jilin University, Changchun/CN [5]Shanghai Chest Hospital, Shanghai/CN [6]The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou/CN [7]Cancer Hospital of Xinjiang Medical University, Urumqi/CN [8]The Fourth Hospital of Hebei Medical University, Shijiazhuang/CN [9]Sichuan Cancer Hospital, Chengdu/CN [10]Cancer Hospital of Shantou University Medical College, Shantou/CN [11]The Second Affiliated Hospital of Nanchang University, Nanchang/CN [12]The First Affiliated Hospital of Dalian Medical University, Dalian/CN [13]Cancer Hospital, Chinese Academy of Medical Sciences, Beijing/CN [14]Taizhou Hospital of Zhejiang Province, Taizhou/CN [15]Qiqihar First Hospital, Qiqihar/CN [16]Huadong Hospital Affiliated To Fudan University, Shanghai/CN [17]Peking University Shenzhen Hospital, Shenzhen/CN [18]West China Hospital of Sichuan University, Chengdu/CN [19]Hubei Cancer Hospital, Wuhan/CN [20]The First Affiliated Hospital of Zhejiang University, Hangzhou/CN [21]Peking University People’s Hospital, Beijing/CN [22]Shanxi Cancer Hospital, Taiyuan/CN [23]Affiliated Hospital of Hebei University, Baoding/CN [24]Zhongshan Hospital Affiliated To Fudan University, Shanghai/CN [25]Beijing Chao-Yang Hospital, Beijing/CN [26]General Hospital of Ningxia Medical University, Yinchuan/CN [27]The First Affiliated Hospital of Soochow University, Suzhou/CN
出处：
ISSN：

关键词： treatment pattern real-world stage III NSCLC

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Shandong Cancer Hospital, Jinan/CN
推荐引用方式(GB/T 7714)：
J. Yu,L. Xing,G. Cheng,et al.Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(3):S367-S368.
APA：
J. Yu,L. Xing,G. Cheng,L. Chen,L. Dong...&J. Zhou.(2021).Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial).JOURNAL OF THORACIC ONCOLOGY,16,(3)
MLA：
J. Yu,et al."Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)".JOURNAL OF THORACIC ONCOLOGY 16..3(2021):S367-S368

相关文献

[1]Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial) [2]Real-world treatment patterns in stage III NSCLC patients: Interim results of a prospective, multicenter, non-interventional study (MOOREA) [3]Real-world adjuvant treatment patterns in patients with stage I-III EGFR-mutated non-small cell lung cancer (NSCLC) in China: Interim analysis from the ADDRESS study [4]Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study [5]Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC [6]A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous NonSmall Cell Lung Cancer (CTONG1506) [7]A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) [8]Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC [9]Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients [10]Preoperative Radiotherapy Decision-Tree for Rectal Cancer Patients: A Real-World Analysis Based on the Swedish Colorectal Cancer Registry

资源点击量：46425 今日访问量：0 总访问量：3323 更新日期：2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号